1 Biosynthesis of GPI-anchored proteins: special emphasis on GPI ...
MARKET NUMBERS COMPANY GPI SHARES · the drivers of the latest rise are renewed government and...
Transcript of MARKET NUMBERS COMPANY GPI SHARES · the drivers of the latest rise are renewed government and...
3
3
HEALTH EXPENDITURE IN ‘OECD’ COUNTRIES AND EUROPE
Source: OECD Website
• Since the end of 2011, OECD countries overall health spending growth closely followed economic growth:
the drivers of the latest rise are renewed government and insurance spending
• EU members devoted an average 10.3% of their GDP to health spending in 2013. The data was up significantly up
from 7.3% in 2000. In Italy, this percentage was lower, and equal to 7,1%, but this gap is gradually narrowing
Public spending as % of GDP
Private spending as % of GDP
10.3 9.0 8.7 8.5 8.4 9.1 7.9 6.8 7.9 6.3 7.1 7.6 7.1 6.0
1.72.6
2.6 2.7 2.7 1.62.4
3.01.8
3.4 2.3 1.52.0
2.9
6.3
2.6
In this context, the
digitalization of the
sector will remain an
important factor for
achieving structural cost
savings for the entire
industry in Italy
4
4
THE CHANGING HEALTHCARE PROVIDER ENVIRONMENT
CLINICAL MODEL
CLINICAL CONTENT
HEALTH METHOD
ORGANIZATION MODEL• Silos
• Isolated
• Provider-centric
• Episodic
• General
• Variable
• Face-to-face
• Data
• Isolated islands
• Manual connection
• Fee of service
• Integrated
• Collaborative
• Patient- and populations-centric
• Coordinated continuity of care
• Precision care
• Standardized
• In-person to virtual care continuum
• Knowledge and insight
• Integrated information
• Automated
• Valued-based
From: To:
6
6
INCOME STATEMENT (IFRS)
* EBITDA ADJUSTED
€ 21.9M
Price adjustment mechanism
thresholds in 2016:
EBITDA € 21.7M
Net income € 5.9M
€M 2016 2015
Turnover 136,2 89,4
SG A (36,5) (27,7)
Labour (79,6) (53,6)
EBITDA (*) 20.1 8,0
EBITDA Margin (%) 14,8% 9,0%
D A (4,8) (5,1)
Risk provisions (0,1) (0,3)
EBIT 15,2 2,6
EBIT Margin (%) 11,2% 2,9
Net financial charges (2,5) (1,8)
Invest. earnings, net fiscal effect 0,1 -
EBT 12,6 0,8
Income tax (6,1) (1,1)
NET INCOME 6,5 (0,3)
o/w net income for the Group 6,2 (0,4)
o/w net income for Minorities 0,3 0,1
(5,2)
(5,7)
0.4 ml Euro
re-allocation
in final release
7
7
BALANCE SHEET
€M 2016 2015 Var %
WORKING CAPITAL (44,4) (28,3) +57%
FIXED ASSETS (52,9) (34,5) +53%
OTHER ASSETS / (LIABILITIES)(26,1) (20,8) +25%
NET INVESTED CAPITAL 71,2 42,0 +70%
EQUITY 61,3 4,3 +>100%
- Group 60,4 4,1
- Third 0,9 0,2
NET FINANCIAL DEBT 9,9 37,8 -74%
EQUITY + NFD 71,2 42,0 +70%
(71.8) Cash & Equivalents
31.8 Bonds
18.1 Long Term Debts
31.8 Short Term Debts
____
9.9 NFD
8
8
CASH FLOW
OPERATING CASH FLOW
€ 7.2M
adjusted € 9.0M
20
16
Note: ITA GAAP consolidated financials
9
9
EXTRACTING VALUE FROM ACQUISITIONS: cases
ACTIVITIES
UNDERTAKEN:
• improvement of the
overall efficiency
• boost on sales
• optimization of staff costs
REORGANIZATION
PROCESS:
• management of
company’s strategic
suppliers, banks and
sponsors
• reorganization of
functions and
responsibilities in the
headquarters (DE)
• re-launch of commercial
activities, exploiting group
sales network
5 months 2015 FY 2016 A (IFRS)
2014 2015 FY 2016 A (IFRS)
TURNOVER EBITDA
TURNOVER EBITDA
TURNOVER EBITDA
TURNOVER DEEP LOSS
8.8
1.1
12.5%13.5%
adj.
26.0
3.6
0.5 1.7 0.13.7
0.5
8% 16 %
Acquisition in Dec 2014
TURNOVER EBITDA
10
10
DETAILS OF OUTSTANDING MINIBONDS
2013 2014 2015 2016 2017 2018 2019-2020 2020-2025
1st minibond – Issue date: 20/12/2013 2nd minibond – Issue date: 29/12/2015 3rd minibond – Issue date: 01/06/2016
Orizzonte
SGR
1st bond
fully
subscribed
€167.5 M
bond out
at 12/15
No debt
payments
€ 31.75 M
Bond out at
09/16
12.00
3.75
8.25
4.754.75
15.0015.00
12.00
7.19
Bond issues
Subscriptions
Repayments
• €12.0M
• Fixed rate 5.50%
• 2013-2018 (bullet)
• Listed on ExtraMOT PRO market
• €4.75M
• Fixed rate 4.25%
• 2015-2025 (amortizing)
• Not listed
• €15.0M
• Fixed rate 4.30%
• 2016-2023 (amortizing)
• Listed on ExtraMOT PRO market
12
12
GROWTH BY M&A: our main strategic guideline for future
DIRECT ITALIAN COMPETITORSi.e. acquisitions in line with market concentration process
OFFER INCREASE within the services offered in the hospital
«VIRTUAL CARE» OUTSIDE HOSPITALwith strong link with social care services
HIGH TECH START UP COMPANIESi.e. “outsourcing” of R&D
GPI is currently evaluating a number of potential acquisitions in different business.
The main drivers for selecting future M&A deals are:
16
16
TOP MANAGEMENT
MANAGER ROLE EXPERIENCE PROFESSIONAL BACKGROUND
FAUSTO
MANZANAChairman and CEO
37 years
(o/w 28 in GPI)Founder of GPI in 1988. Operating in the IT sector
LORENZO
MONTERMINIMarketing Director
19 years
(o/w 19 in GPI)CTO from 2001 to 2014. Marketing director since 2014
PAOLO
GIRARDIGeneral Manager
20 years
(o/w 12 in GPI)CEO of Ecopulp Srl
STEFANO
CORVOCFO
28 years
(o/w 2 in GPI)Mediocredito Trentino Alto Adige and CFO of Diatec Group
EMANUELE
ROSSICTO and Head of IT
Solutions
15 years
(o/w 10 in GPI)Accenture (2003-07) and then various roles in the GPI Group
RUGGERO
PEDRI
Head of Professional
IT Services
27 years
(o/w 25 in GPI)Various roles in the GPI Group
MAURIZIO
BOSCHETTISales Director
21 years
(o/w 21 in GPI)Various roles in the GPI group
17
17
VALUABLE PARTNERSHIPS and QUALITY CERTIFICATIONS
PARTNERS
PARTNERS
Call Center ServicesUNI EN 15838:2010
COGEBAN
405010
20
20
Bloomberg GPI:IM
Reuters GPI.MI
ISIN IT0005221517
Share Capital € 8,526,331.90 par value
5,339,969 Ordinary Sh.
10,000,000 B Sh.
114,975 C Sh.
Market Cap € 55.1 m (March, 31)
Price € 10.32 (March, 31)
NomAd Banca Akros
Specialist UBI Banca
SHARE
Code WGPI
ISIN IT0005221475
Price € 1.362
(March, 31)
Outstanding
Warrants
2,554,700
WARRANT
Holder N. of Shares % (voting rights)
FM Srl 319,000 Ordinary S.
9,268,000 B
74.41%
Orizzonte
SGR SpA*
732,000 B 5.78%
*on behalf of the closed fund
"Information & Communication Technology"
SHAREHOLDINGS
BOND 5,5% 2013-18
ISIN IT0004981913
Market Extramot PRO
Issued
Value
€ 12.0 m
GPI ON AIM ITALIA
21
21
WARRANTS: warrantholder wealth unchanged
• GPI BoD set Warrant Subscription Price to 9,5 € per share from 0,1 € per share.
• By consequence the exchange ratio is now 1:1 (shares:warrants) and the maximum amount of new shares is 2.5 MLN for a capital
contribution of approx. 24.2 MLN/€.
• The adjustment is permanent and does not alter nor warrantholders position neither diluition effects.
An illustrative example @ 13,30 € of share market price
FROM THE COMPANY POINT OF VIEW FROM WARRANTHOLDERS POINT OF VIEW
22
22
GPI-CFP1 BUSINESS COMBINATION
GPI VALUATION:
€ 100 M
STRUCTURE OF THE TRANSACTION
A cashless mechanism for the warrant price adjustment is
linked to 2016 financial results and will be through the free
allocation of existing shares by FM (Manzana Family holding)
in favor of ordinary shareholders.
Price Adjustment (max 10% FM -> 9 m/€), if:
EBITDA* < 21.7 m/€ < 23.0 m/€
Implied multiple 6.5x 5.75x
NET RESULT* < 5.9 m/€
Implied multiple 16.5x
*With 5% allowance, equal scope of consolidation, in IFRS excluding
transaction costs and M&A
Share-exchange ratio1:1
GPI 100.0 € m 10.0 m Shares @ 10€
CFP1 52.6 € m 5.3 m Shares @ 10€
Thanks to the Business Combination and the IPO the company aims to:
• strengthen its presence in Italy and abroad
• achieve internationalisation in the reference markets (pharmaceutical logistics and information systems)
• grow through M&As with main industry players
WARRANT PRICE ADJUSTMENT
Outstanding
Granted to
non-dissenting
Holders
Performance
acceleration
Strike price
Share
underwriting
ratio
WARRANTS
1.5 m (3:10)
1 m (2:10 in IPO)
5 years
(with acceleration
> 13.3 € in case of listing)
9.5€
Floating Sh. A – 9.5€
Floating Sh. A - Strike price
24
24
Maria Antonietta Pireddu
T +39 02 45473884
www.irtop.com
Stefano Corvo
T +39 0461 381515
TRENTO
www.gpi.it